MAST²CARE (Mastocytosis Centers of Reference and Excellence)

MAST²CARE, launched in 2024, aims to address an important gap by promoting innovation and evidence-based practice through research and publications. The initiative seeks to increase awareness of mastocytosis among physicians, the pharmaceutical industry, and patients. To achieve this, MAST²CARE is building a global network and strengthening professional relationships to advance state-of-the-art expert care in the management of mastocytosis. In support of patients living with mastocytosis, they have also provided the MASTHAVE App since 2024.